LEXICON PHARMACEUTICALS, INC. (LXRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, LEXICON PHARMACEUTICALS, INC. reported revenue of $49.80M, up 60.2% from the prior year. The company ran a net loss, with a net margin of -101.1%. It held $184.99M in total assets against $77.45M in total liabilities.
Key ratios (FY2025)
-98.2%
Operating margin
-101.1%
Net margin
-46.8%
Return on equity
+60.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.80M | $31.08M | $1.20M | $139.0K | $298.0K | $24.00M | $322.07M | $63.21M | $91.69M | $79.26M |
| Cost of Revenue | $274.0K | $616.0K | $85.0K | $0 | $0 | $1.93M | $3.23M | $2.49M | $1.90M | $0 |
| Operating Income | -$48.91M | -$197.12M | -$171.75M | -$100.76M | -$87.09M | -$47.80M | $141.44M | -$103.28M | -$130.62M | -$127.17M |
| Net Income | -$50.34M | -$200.40M | -$177.12M | -$101.94M | -$87.76M | -$58.57M | $130.13M | -$120.55M | -$122.99M | -$131.44M |
| EPS (Diluted) | $-0.14 | $-0.63 | $-0.80 | $-0.62 | $-0.60 | $-0.53 | $1.16 | $-1.14 | $-1.17 | — |
| Total Assets | $184.99M | $298.42M | $229.43M | $194.30M | $136.91M | $203.79M | $417.71M | $284.14M | $436.54M | $475.62M |
| Total Liabilities | $77.45M | $152.47M | $136.32M | $77.17M | $23.31M | $47.42M | $300.61M | $310.54M | $368.27M | $318.22M |
| Shareholders' Equity | $107.54M | $145.95M | $93.11M | $117.12M | $113.59M | $156.37M | $117.10M | -$26.41M | $68.27M | $167.51M |
| Cash & Equivalents | $34.33M | $66.66M | $22.46M | $46.34M | $64.06M | $126.26M | $36.11M | $80.39M | $61.66M | $46.60M |
| Operating Cash Flow | -$67.85M | -$178.78M | -$161.90M | -$88.85M | -$87.02M | -$142.97M | $113.81M | -$148.61M | -$185.39M | -$175.63M |
| Capital Expenditures | $0 | $1.03M | $470.0K | $1.33M | $1.22M | $87.0K | $70.0K | $95.0K | $228.0K | $231.0K |
| Shares Outstanding | 363.05M | 320.03M | 221.13M | 165.73M | 145.65M | 110.84M | 116.75M | 105.83M | 105.24M | — |